venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 15, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 9
- −1 vs. Q1 2022
- Portfolio value
- $351.2M
- −$99.9M (−22.1%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $78.5M | 22.3% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,448,720 | $70.7M | 20.1% | −95,764−6.2% | Reduced | History |
| VTYXVentyx Biosciences, Inc. | COM | 5,011,536 | $61.3M | 17.5% | 00.0% | Unchanged | History |
| PHVSPharvaris N.V. | COM | 2,301,451 | $50.9M | 14.5% | −1,859−0.1% | Reduced | History |
| CINCCinCor Pharma, Inc. | COM | 2,145,035 | $40.4M | 11.5% | +164,329+8.3% | Added | History |
| IMPLIPI Legacy Liquidation Co | COM | 2,759,791 | $25.7M | 7.3% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 2,171,664 | $20.5M | 5.8% | 00.0% | Unchanged | History |
| ELEVElevation Acquisition Group Inc. | COM | 1,866,339 | $2.61M | 0.7% | −741,828−28.4% | Reduced | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 161,897 | $678.0K | 0.2% | 00.0% | Unchanged | History |
Sold out since Q1 2022 (1)
Positions held at the end of Q1 2022 that are gone from this filing.